Performance effect of the content of alloying elements in the development of high entropy alloys of the Ti-Nb-Zr-Ta-Mo family for biomedical applications
- Autores: Ghaith Kamel Mohammad Al Hawajreh
- Directores de la Tesis: José Gonzalo González Reyes (dir. tes.), Vicente Amigó Borrás (dir. tes.)
- Lectura: En la Universitat Politècnica de València ( España ) en 2024
- Idioma: inglés
- Tribunal Calificador de la Tesis: María Teresa Pérez-Prado (presid.), David Busquets Mataix (secret.), Alejandro Manzano Ramírez (voc.)
- Programa de doctorado: Programa de Doctorado en Ingeniería y Producción Industrial por la Universitat Politècnica de València
- Materias:
- Enlaces
- Tesis en acceso abierto en: RiuNet
- Resumen
Biomedical high entropy alloys (Bio-HEAs) with non-toxic properties, synthesized through powder metallurgy methods, have received limited attention despite their potential for favorable mechanical and biological performance. This study aimed to systematically investigate the microstructural, mechanical, electrochemical, and ion release features of distinct porous alloy compositions organized into three groups. Group one consisted of four porous TNZT EB alloys with varied Ti/Ta ratios, while group two comprised two porous TNZTM EB alloys with different Ti/Mo ratios. Lastly, group three included two porous TNZT SPS alloys with varying Ti/Ta ratios.
In the microstructure analysis of TNZT EB alloys, the presence of semi-equiaxed and micrometric BCC phases (matrix) with lower HCP phase content was evident. Mechanical properties, encompassing elastic moduli (83-100 GPa), hardness (373-430 HVN), ultimate bending (225-476 MPa), tensile (120-256 MPa) strength, and compression (713-1410 MPa), in addition to electrochemical corrosion (4.5-9.6 mum year-1) and ion release (toxicity, 0.04-1.1 mum year-1), fell within acceptable limits for implant biomaterials. Remarkably, augmenting the Ti content (and decreasing Ta) exhibited advantages in improving mechanical strength and reducing the elastic modulus.
The microstructure of group two, specifically the Ti20 EB TNZTM alloys, exhibited semi-equiaxed and micrometric BCC phases (matrix) with diminished proportions of FCC and HCP phases. Conversely, in Ti25 EB TNZTM, the microstructure comprised semi-equiaxed and micrometric FCC-phases (matrix) with reduced quantities of HCP and BCC phases. It is noteworthy to underscore the challenge of weak homogeneity leading to evident heterogeneity in TNZTM EB alloys. The mechanical properties, including elastic moduli (78-80 GPa), hardness (257-294 HVN), ultimate bending (186-210 MPa), tensile (121-144 MPa) strength, compression (661-774 MPa), electrochemical corrosion (5-6.6 mum year-1), and ion release (toxicity, 0.3-0.8 mum year-1), fell within acceptable ranges for implant biomaterials. The advantageous reduction of elastic modulus and ion releases was achieved by decreasing the Ti content (and increasing Mo), whereas enhancing mechanical strengthening was facilitated by increasing the Ti content (and decreasing Mo).
Group three, TNZT SPS alloys, exhibited a microstructure with semi-equiaxed and micrometric BCC-phases (matrix) and lower HCP and FCC phase content. The elastic moduli (85-88 GPa), hardness (268-349 HVN), and ultimate bending (225-476 MPa), and electrochemical corrosion (4.7-5.1 mum year-1). Increasing Ti content (and decreasing Ta) were advantageous for reducing the elastic modulus and improving hardness.
The moderate elastic modulus value holds potential benefits in alleviating the mechanical incongruence between the implant and organic tissue. Nevertheless, in the case of group one (TNZT EB), the corrosion rate exhibited an upward trend, while the metallic ion release declined with increasing Ti content. In contrast, for group two (TNZTM EB), both the corrosion rate and metallic ion release diminished in response to escalating Ti content. Within group three (TNZT SPS) there was increase in the corrosion rate as the Ti content escalated.
Based on the above, porous TNZT EB alloys with medium and highest Ti contents (Ti30 EB and Ti35 EB) emerged as promising candidates for biomedical implant applications
